Barely Surviving To Thriving - A Remarkable 27-year Journey With HIV
OTTAWA, Nov. 26, 2012 /CNW/ - Tiko Kerr doesn't look sick. He's a healthy and active man who rows four times a week. He defies anyone's image of a man who has lived with HIV for almost 30 years.
Tiko was diagnosed with HIV in 1985 while living in Australia; he took it as a death sentence. If the virus didn't kill him, the medication available at that time might. Little was known about HIV when Tiko was diagnosed, medications where only just being researched and the stigma and fear associated with HIV/AIDS where overwhelming.
"In those days there were not a lot of medication options, people were dying," said Tiko.
Returning to Canada and settling in Vancouver to focus on his artwork, Tiko struggled to keep his disease in check. Over the next 20 years he would take every new medicine developed. As the virus gained strength, Tiko became resistant to one medication after another, barely keeping Tiko alive."By 2005 I was taking every drug available," said Tiko. "I was in an advanced stage and I soon became completely drug resistant." Tiko learned of a new treatment option but the medicine wasn't yet available in Canada. Tiko, his doctor and a group of individuals with HIV banded together and became advocates to gain access to the new treatment. But time was off the essence. Tiko's viral load, a measurement of the amount of virus in the body, was 700 thousand. Others were dying with a viral load of 500 thousand. "I didn't have much time," said Tiko. "One man in our group had passed away and I knew I was dying. I needed to take more action." Tiko gathered significant public support and finally, in 2006, was granted access through a small clinical trial to the latest treatment. The changes were immediate and they were staggering. Within 5 days of treatment, Tiko's viral load was reduced by 90%. Within a month, the HIV virus was no longer detectable in his body.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV